LRRK2 and Parkinson disease: LRRK2-mediated phosphorylation of Rab7L1 increases TGN fragmentation and PD-associated LRRK2 mutants demonstrate highly increased Rab7L1 phosphorylation rates (Fujimoto et al., 2018).